Abstract
Objectives To investigate the impact of yellow fever (YF) vaccination in the context of an outbreak and its association with migration, by assessing the effects of herd immunity in endemic communities and caravans, and its potential spread to other subsequent at-risk, disease-free communities in the migratory route.
Methods We use a SEIRV-SEI compartmental deterministic model for humans and vectors and numerical simulations applied to three coupled populations - caravans, endemic and disease-free communities. Two scenarios are evaluated with different vaccination coverage levels at endemic communities and in caravans.
Results When communities endemic to YF are the source of migration, herd immunity is critical, but vaccinating caravans is by far the most significant intervention to protect migrants and disease-free communities upwards from the risk of YF introduction.
Conclusion Preventing outbreaks of climate-sensitive infectious diseases in the context of migration must be a joint effort of common interest. Maintaining vaccination coverage at recommended levels combined with the continued effort to vaccinate people on the move is the only intervention that can prevent a health crisis. Therefore, vaccination against climate-sensitive diseases should be considered climate adaptation.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the Coordination for the Improvement of Higher Education Personnel (CAPES), grant: 88882.378281/2019-01. The authors declare that they have not entered into an agreement with the funder in a way that could have limited the ability to complete the research as planned. Therefore, we affirm that we fully control all primary data.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript.
